| scholarly article | Q13442814 |
| P2093 | author name string | C C Kuo | |
| J T Grayston | |||
| Z P Yang | |||
| P2860 | cites work | Infections caused by Chlamydia pneumoniae strain TWAR | Q35535575 |
| Identification of a new group of Chlamydia psittaci strains called TWAR. | Q37213605 | ||
| Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol | Q37240380 | ||
| Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques | Q37892518 | ||
| Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979 | Q37892533 | ||
| A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. | Q37896100 | ||
| A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. | Q37896793 | ||
| Chlamydia trachomatis pneumonitis in the C57BL/KsJ mouse: pathologic and immunologic features. | Q37907620 | ||
| A mouse model of pneumonitis induced by Chlamydia trachomatis: morphologic, microbiologic, and immunologic studies. | Q37909876 | ||
| A mouse model of Chlamydia trachomatis pneumonitis | Q37910159 | ||
| Inapparent respiratory infection of inbred Swiss mice with sulfadiazine-resistant, iodine-negative Chlamydiae | Q37913812 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chlamydia pneumoniae | Q62869737 |
| P304 | page(s) | 2037-2040 | |
| P577 | publication date | 1993-05-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis | |
| P478 | volume | 61 |
| Q37874025 | A case of splenic abscess due to Chlamydia pneumoniae |
| Q34082096 | A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1 |
| Q34003385 | Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge |
| Q37858591 | Acute primary Chlamydophila pneumoniae bronchitis and bronchial hyperresponsiveness in young nonasthmatic Thai military recruits |
| Q37879491 | Animal models for Chlamydia pneumoniae infection |
| Q37883441 | Atypical respiratory pathogens |
| Q37881299 | Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells |
| Q35367697 | Chlamydia pneumoniae (TWAR). |
| Q35395532 | Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods |
| Q37867591 | Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice |
| Q35035253 | Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis |
| Q34009858 | Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro |
| Q37868415 | Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. |
| Q37855601 | Chronic and repeated Chlamydophila pneumoniae lung infection can result in increasing IL-4 gene expression and thickness of airway subepithelial basement membrane in mice |
| Q37862676 | Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo |
| Q37866631 | DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. |
| Q37877956 | Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice |
| Q37888651 | Detection of Chlamydia trachomatis deoxyribonucleic acid in monkey models (Macaca nemestrina) of salpingitis by in situ hybridization: implications for pathogenesis |
| Q37864671 | Development of a hamster model of Chlamydophila pneumoniae infection. |
| Q37862482 | Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood |
| Q34005431 | Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice |
| Q33979917 | Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice |
| Q35110637 | Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis |
| Q37871964 | Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue |
| Q37887313 | Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization |
| Q37867617 | Experimental infection by Chlamydia pneumoniae in the hamster |
| Q35169692 | Experimental models of pulmonary infection |
| Q35774105 | Experimental rabbit models of Chlamydia pneumoniae infection |
| Q41779449 | Immunology of non-trachomatis chlamydial infection |
| Q35915081 | Infection and Atherosclerosis Development |
| Q37879018 | Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes |
| Q37857618 | Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model |
| Q35947625 | Mouse Model of Respiratory Tract Infection Induced by Waddlia chondrophila. |
| Q37861476 | Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae |
| Q33762134 | Pathologic manifestation of Chlamydial infection |
| Q34995600 | Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model |
| Q37883934 | Rabbit model for Chlamydia pneumoniae infection |
| Q35118114 | Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents |
| Q37568474 | Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice |
| Q33429029 | The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection |
| Q37880009 | The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection |
| Q37728659 | Type 1 T-cell responses in chlamydial lung infections are associated with local MIP-1alpha response. |
| Q73382390 | Vaccination against infections by Chlamydia pneumoniae |
| Q37877532 | Value of animal models for Chlamydia pneumoniae-related atherosclerosis |
Search more.